{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:12:18Z","timestamp":1783152738309,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113765"],"award-info":[{"award-number":["R01NS113765"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS109762"],"award-info":[{"award-number":["R21NS109762"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bbadis.2024.167091","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T03:22:03Z","timestamp":1708744923000},"page":"167091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The contribution and therapeutic implications of IGHMBP2 mutations on IGHMBP2 biochemical activity and ABT1 association"],"prefix":"10.1016","volume":"1870","author":[{"given":"Gangadhar P.","family":"Vadla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique A.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167091_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng703","article-title":"Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1","volume":"29","author":"Grohmann","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajhg.2014.10.002","article-title":"Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2","volume":"95","author":"Cottenie","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0015","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1111\/ene.15024","article-title":"Genotype and phenotype distribution of 435 patients with Charcot-Marie-Tooth disease from central south China","volume":"28","author":"Xie","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.nmd.2022.05.002","article-title":"Clinical and genetic features of Charcot-Marie-Tooth disease patients with IGHMBP2 mutations","volume":"32","author":"Lei","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2024.167091_bb0025","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/brain\/awg278","article-title":"Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1","volume":"126","author":"Pitt","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2024.167091_bb0030","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.10755","article-title":"Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"54","author":"Grohmann","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.10182","article-title":"Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13","volume":"51","author":"Viollet","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nmd.2016.11.008","article-title":"IGHMBP2-related clinical and genetic features in a cohort of Chinese Charcot-Marie-Tooth disease type 2 patients","volume":"27","author":"Liu","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2024.167091_bb0045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.nmd.2015.07.017","article-title":"Autosomal recessive axonal polyneuropathy in a sibling pair due to a novel homozygous mutation in IGHMBP2","volume":"25","author":"Wagner","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2024.167091_bb0050","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.15252\/embj.201696174","article-title":"Sen1 has unique structural features grafted on the architecture of the Upf1-like helicase family","volume":"36","author":"Leonaite","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2024.167091_bb0055","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1017\/S1355838200992392","article-title":"Mtt1 is a Upf1-like helicase that interacts with the translation termination factors and whose overexpression can modulate termination efficiency","volume":"6","author":"Czaplinski","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.bbadis.2024.167091_bb0060","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1038\/s41467-018-06313-y","article-title":"UPF1-like helicase grip on nucleic acids dictates processivity","volume":"9","author":"Kanaan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167091_bb0065","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1093\/nar\/gkz409","article-title":"Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis","volume":"47","author":"Jia","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2024.167091_bb0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41580-023-00628-5","article-title":"Cellular functions of eukaryotic RNA helicases and their links to human diseases","volume":"24","author":"Bohnsack","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.886563","article-title":"RNA helicases in microsatellite repeat expansion disorders and neurodegeneration","volume":"13","author":"Castelli","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0080","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1038\/s41467-020-17129-0","article-title":"C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167091_bb0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1261\/rna.079188.122","article-title":"Modulation of RNA-binding properties of the RNA helicase UPF1 by its activator UPF2","volume":"29","author":"Xue","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.bbadis.2024.167091_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng1303","article-title":"Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2","volume":"36","author":"Moreira","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","article-title":"DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)","volume":"74","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167091_bb0100","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awab464","article-title":"Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4","volume":"145","author":"Kannan","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2024.167091_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/awz373","article-title":"ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy","volume":"143","author":"Kannan","year":"2020","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164608","article-title":"ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity","volume":"8","author":"Vadla","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2024.167091_bb0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/humu.9241","article-title":"Allelic heterogeneity of SMARD1 at the IGHMBP2 locus","volume":"23","author":"Maystadt","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2024.167091_bb0120","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1542\/peds.2011-0544","article-title":"The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"129","author":"Eckart","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbadis.2024.167091_bb0125","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1093\/nar\/gks792","article-title":"The Ighmbp2 helicase structure reveals the molecular basis for disease-causing mutations in DMSA1","volume":"40","author":"Lim","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2024.167091_bb0130","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/hmg\/ddp028","article-title":"IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)","volume":"18","author":"Guenther","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0135","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddab317","article-title":"The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects","volume":"31","author":"Smith","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmb.2012.09.010","article-title":"Structural basis for 5\u2032-end-specific recognition of single-stranded DNA by the R3H domain from human Smubp-2","volume":"424","author":"Jaudzems","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-2836(02)01381-5","article-title":"Solution structure of the R3H domain from human Smubp-2","volume":"326","author":"Liepinsh","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167091_bb0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","article-title":"Performance and its limits in rigid body protein-protein docking","volume":"28","author":"Desta","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.bbadis.2024.167091_bb0160","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/mt.2016.33","article-title":"Rescue of a mouse model of spinal muscular atrophy with respiratory distress type 1 by AAV9-IGHMBP2 is dose dependent","volume":"24","author":"Shababi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2024.167091_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.omtm.2021.07.008","article-title":"Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB\/NJ-Ighmpb2 (nmd-2J)","volume":"23","author":"Shababi","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bbadis.2024.167091_bb0170","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddh222","article-title":"Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"13","author":"Grohmann","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molcel.2013.08.011","article-title":"The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of Pre-rRNA processing factors","volume":"51","author":"Tafforeau","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2024.167091_bb0180","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1128\/MCB.25.13.5523-5534.2005","article-title":"Esf2p, a U3-associated factor required for small-subunit processome assembly and compaction","volume":"25","author":"Hoang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","article-title":"Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III","volume":"9","author":"Jablonka","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2024.167091_bb0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nsmb1330","article-title":"NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity","volume":"15","author":"Chamieh","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2024.167091_bb0195","doi-asserted-by":"crossref","first-page":"10050","DOI":"10.1073\/pnas.1000993107","article-title":"Insights into the recruitment of the NMD machinery from the crystal structure of a core EJC-UPF3b complex","volume":"107","author":"Buchwald","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:43:37Z","timestamp":1751215417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0925443924000802"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167091","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution and therapeutic implications of IGHMBP2 mutations on IGHMBP2 biochemical activity and ABT1 association","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167091"}}